1 of 5

Long Story Short Episode 73: Metformin for Long COVID

Metformin for Long COVID

In this study, researchers demonstrated that the use of metformin within the first four days of COVID-19 symptoms reduced healthcare utilization and the incidence of long COVID. The researchers write: “In conclusion, early outpatient COVID-19 treatment with metformin decreased the subsequent risk of long COVID by 41.3% during 10-month follow-up. This finding is consistent with the 42.3% reduction in healthcare utilization for severe COVID-19 with metformin in the first 14 days of the trial.”

Share this Lesson
We use cookies on this site to enhance your user experience. By clicking the Accept button, you agree to us doing so. Read our Privacy Policy ACCEPT